Parabolic Drugs has informed that with reference to e-mail dated 21-12-2017, in regard to deficiency observed in the financial result for the Quarter/Half year ended on 30th September, 2017 with respect to the point, Reconciliation of Profit and Loss not submitted.
The above information is a part of company’s filings submitted to BSE